Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Journal of Mass Spectrometry and Advances in the Clinical Lab
|
May 23, 2022
A rapid LC-MS/MS assay for detection and monitoring of underivatized branched-chain amino acids in maple syrup urine disease
Hamed Piri-Moghadam, Alan Miller, Debra Pronger, et al.
Cancer Investigation
|
November 25, 2003
Neuronal stem cells biology and plasticity
Vincent F La Russa, Debasis Mondal, Alan Miller, et al.
Research on Aging
|
August 19, 2023
Promoting Sustainability in Housing with Services: Insights From the Right Care, Right Place, Right Time Program
Pamela Nadash, Edward Alan Miller, Elizabeth Simpson, et al.
Circulation. Heart Failure
|
February 26, 2011
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial
Markus Haass, Dalane W Kitzman, Inder S Anand, et al.
Cardiology Research
|
January 5, 2026
Epidemiological Trends of Heart Failure Subtypes, Characteristics, and Outcomes Within Inpatient Hospitalizations
Kayhon Rabbani, Cloie June Chiong, Roy Mendoza, et al.
The American Journal of Cardiology
|
September 6, 2011
Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes
Christopher M O'Connor, Mona Fiuzat, Joann Lindenfeld, et al.
American Heart Journal
|
October 12, 2010
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])
Peter Carson, Mona Fiuzat, Christopher O'Connor, et al.
JACC. Heart Failure
|
March 14, 2014
The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results
Peter Carson, John Wertheimer, Alan Miller, et al.
JACC. Heart Failure
|
May 19, 2015
The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction)
Peter E Carson, Inder S Anand, Sithu Win, et al.
JACC. Heart Failure
|
March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial
Peter Carson, John R Teerlink, Michel Komajda, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Journal of Mass Spectrometry and Advances in the Clinical Lab
|
May 23, 2022
A rapid LC-MS/MS assay for detection and monitoring of underivatized branched-chain amino acids in maple syrup urine disease
Hamed Piri-Moghadam, Alan Miller, Debra Pronger, et al.
Cancer Investigation
|
November 25, 2003
Neuronal stem cells biology and plasticity
Vincent F La Russa, Debasis Mondal, Alan Miller, et al.
Research on Aging
|
August 19, 2023
Promoting Sustainability in Housing with Services: Insights From the Right Care, Right Place, Right Time Program
Pamela Nadash, Edward Alan Miller, Elizabeth Simpson, et al.
Circulation. Heart Failure
|
February 26, 2011
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial
Markus Haass, Dalane W Kitzman, Inder S Anand, et al.
Cardiology Research
|
January 5, 2026
Epidemiological Trends of Heart Failure Subtypes, Characteristics, and Outcomes Within Inpatient Hospitalizations
Kayhon Rabbani, Cloie June Chiong, Roy Mendoza, et al.
The American Journal of Cardiology
|
September 6, 2011
Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes
Christopher M O'Connor, Mona Fiuzat, Joann Lindenfeld, et al.
American Heart Journal
|
October 12, 2010
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])
Peter Carson, Mona Fiuzat, Christopher O'Connor, et al.
JACC. Heart Failure
|
March 14, 2014
The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results
Peter Carson, John Wertheimer, Alan Miller, et al.
JACC. Heart Failure
|
May 19, 2015
The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction)
Peter E Carson, Inder S Anand, Sithu Win, et al.
JACC. Heart Failure
|
March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial
Peter Carson, John R Teerlink, Michel Komajda, et al.
Page
of 14